📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Dyax

1.1 - Company Overview

Dyax Logo

Dyax

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotherapeutics focused on the discovery, development and commercialization for unmet medical needs, with an emphasis on inflammatory and oncology indications; lead product DX-88 approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Dyax

FibroBiologics Logo

FibroBiologics

HQ: United States Website
  • Description: Provider of fibroblast cell-based regenerative therapies for chronic diseases, including multiple sclerosis (immune modulation and tissue regeneration), CybroCell universal donor cellular product for degenerative disc disease (disc regeneration and inflammation reduction), wound healing, and therapies to improve and extend the productive life of the thymus and enhance spleen function.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full FibroBiologics company profile →
Cephalon Logo

Cephalon

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery, development, and commercialization of medications to improve quality of life worldwide. Founded in 1987, the company delivers first-in-class and best-in-class medicines across several therapeutic areas.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cephalon company profile →
Vertex Pharmaceuticals Logo

Vertex Pharmaceuticals

HQ: United States Website
  • Description: Provider of small molecule drugs for serious diseases, including cystic fibrosis medicines, and research and development of therapies for sickle cell disease, type 1 diabetes, APOL1-mediated kidney disease, pain management, and beta thalassemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vertex Pharmaceuticals company profile →
ARMO BioSciences Logo

ARMO BioSciences

HQ: United States Website
  • Description: Provider of immune modulatory biologic therapeutics, from a biotechnology company based in Redwood City, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ARMO BioSciences company profile →
Exzell Pharma Logo

Exzell Pharma

HQ: Canada Website
  • Description: Provider of medicines, healthcare and biopharma-based products, including EsopH OTC therapy for GERD that relieves heartburn and can be used with PPI prescriptions; Swiss Natural vitamins, supplements and minerals from natural sources; Salinex nasal spray to hydrate and cleanse; PediaVit vitamins and iron for infants and children; Koena multi-strain probiotics; and Ozonol ointment for scrapes, minor burns, and skin irritations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exzell Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Dyax

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Dyax

2.2 - Growth funds investing in similar companies to Dyax

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Dyax

4.2 - Public trading comparable groups for Dyax

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Dyax

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Dyax

What does Dyax do?

Dyax is a provider of biotherapeutics focused on the discovery, development and commercialization for unmet medical needs, with an emphasis on inflammatory and oncology indications; lead product DX-88 approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug.

Who are Dyax's competitors?

Dyax's competitors and similar companies include FibroBiologics, Cephalon, Vertex Pharmaceuticals, ARMO BioSciences, and Exzell Pharma.

Where is Dyax headquartered?

Dyax is headquartered in United States.

How many employees does Dyax have?

Dyax has 1,000 employees 🔒.

When was Dyax founded?

Dyax was founded in 2010 🔒.

What sector and industry vertical is Dyax in?

Dyax is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Dyax

Who are the top strategic acquirers in Dyax's sector and industry

Top strategic M&A buyers and acquirers in Dyax's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Dyax?

Top strategic M&A buyers groups and sectors for Dyax include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Dyax's sector and industry vertical

Which are the top PE firms investing in Dyax's sector and industry vertical?

Top PE firms investing in Dyax's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Dyax's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Dyax's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Dyax's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Dyax include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Dyax's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Dyax?

The key public trading comparables and valuation benchmarks for Dyax include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Dyax for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Dyax with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Dyax's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Dyax with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Dyax's' sector and industry vertical?

Access recent funding rounds and capital raises in Dyax's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Dyax